Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases

Hematopoietic stem cell transplant (HSCT) recipients may be at high risk of mortality from coronavirus disease 2019 (COVID-19). However, specific data on COVID-19 after treatment with HSCT in patients affected by autoimmune diseases (ADs) are still lacking. In this multicenter observational study of...

Descripción completa

Detalles Bibliográficos
Autores principales: Greco, Raffaella, Snowden, John A., Knelange, Nina Simone, Tridello, Gloria, Cacciatore, Carlotta, Xhaard, Alienor, Ciceri, Fabio, Collin, Matthew, Ferra, Christelle, De Becker, Ann, Badoglio, Manuela, Averbuch, Dina, Alexander, Tobias, Ljungman, Per, De la Camara, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977622/
https://www.ncbi.nlm.nih.gov/pubmed/37001437
http://dx.doi.org/10.1016/j.jaut.2023.103024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977622/
https://www.ncbi.nlm.nih.gov/pubmed/37001437
http://dx.doi.org/10.1016/j.jaut.2023.103024

Ejemplares similares